PVX4 for the Treatment of Human Papilloma Virus (HPV)16+ Cervical Dysplasia

NCT07454915 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

138

Enrollment

OTHER

Sponsor class

Conditions

Cervical Intraepithelial Neoplasia Grade 2/3
Human Papilloma Virus Infection Type 16

Interventions

COMBINATION_PRODUCT: PVX4 Combination Product
OTHER: Placebo Control

Sponsor

PapiVax Biotech, Inc.